BNP Levels May Not Be Effective Prognostic Tool for Patients With Cardiogenic Shock Using VADs

While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist devices (VADs).

Related Keywords

United States ,American ,Pankaj Arora ,Division Of Cardiovascular Disease ,American Journal ,Cardiovascular Disease ,Heart Failure ,Lvad ,Bnp Levels ,Prognostic Tool ,Cardiogenic Shock ,